Dr. Jonathan Vilasier Iralu, MD

Dr. Iralu practices at Gallup Indian Medical Center - Laboratory in Gallup, New Mexico.

Dr. Iralu's NPI, 1396774204, was assigned on July 2, 2006. Dr. Iralu graduated from Harvard Medical School in 1987. Dr. Iralu holds New Mexico license 95-259.

Dr. Iralu's primary practice is Gallup Indian Medical Center - Laboratory, at 516 E Nizhoni, Gallup, NM 87301. The practice phone is (505) 409-8018.

Dr. Iralu's primary practice is Gallup Indian Medical Center - Laboratory in Gallup, New Mexico. Dr. Iralu is also affiliated with Gallup Indian Medical Center. The medical group on file is Gallup Indian Medical Center. Dmand AI also links Dr. Iralu to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Iralu practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Iralu's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Iralu is board certified in infectious disease by the American Board of Internal Medicine. Dr. Iralu is licensed in New Mexico.

Dmand AI lists acute skin infection, adjustment disease, asthma, chronic diabetes, chronic hypertension, chronic kidney disease, chronic obstructive pulmonary disease (COPD) and cirrhosis of the liver among the conditions Dr. Iralu treats.

CMS data shows 176 Medicare services from Dr. Iralu across 2 procedure codes in 2024, all of them office visits, for 70 Medicare patients. Medicare paid $10,382 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 70 Medicare patients who saw Dr. Iralu in 2024. The largest group is 65 to 74, with 28 patients. 73% of them have high cholesterol, and 67% have high blood pressure. 59% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Iralu's median patient age at 72, with 59% women.

In 2024, Dr. Iralu wrote 1,535 Medicare Part D claims for 87 patients. 52% of them were for generic drugs. CMS names the drug for 1,198 of them, across 39 drugs with 11 or more claims each, at $904,228 in total drug cost. In 2023, CMS named 1,352 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Iralu for performance year 2024, reported as part of a group. Dr. Iralu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Iralu as offering telehealth.

Dmand AI links 12 papers to Dr. Iralu, published from 2018 to 2020. The most frequent topics are Indians, North American, United States Indian Health Service and Base Sequence. Dr. Iralu has published most often in Public Health Rep. Dr. Iralu's most frequent co-authors are Melissa G. Collier, FAAP, MD, MPH and Powel H. Kazanjian, MD.

Dr. Iralu graduated from Harvard Medical School in 1987. Dr. Iralu is a member of ACP and IDSA.

Dr. Iralu is in network with 3 carriers, including Humana, Molina and CMS Medicare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.